Your browser doesn't support javascript.
loading
Correction to: Role of dopamine agonists in Parkinson's disease therapy.
Woitalla, D; Buhmann, C; Hilker-Roggendorf, R; Höglinger, G; Koschel, J; Müller, T; Weise, D.
Affiliation
  • Woitalla D; Department of Neurology, Katholische Kliniken Der Ruhrhalbinsel, Essen, Germany. D.Woitalla@kkrh.de.
  • Buhmann C; Department of Neurology, Universitätsklinikum Hamburg, Hamburg, Germany.
  • Hilker-Roggendorf R; Department of Neurology, Klinikum Vest, Recklinghausen, Germany.
  • Höglinger G; Department of Neurology, Medizinische Hochschule Hannover, Hannover, Germany.
  • Koschel J; Department of Neurology Parkinson-Klinik Ortenau, Wolfach, Germany.
  • Müller T; Department of Neurology, Alexianer St. Joseph Krankenhaus, Berlin, Germany.
  • Weise D; Department of Neurology, Asklepios Fachklinikum Stadtroda, Stadtroda, Germany.
J Neural Transm (Vienna) ; 2023 Sep 13.
Article in En | MEDLINE | ID: mdl-37702775
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neural Transm (Vienna) Year: 2023 Document type: Article Affiliation country: Germany Country of publication: Austria
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neural Transm (Vienna) Year: 2023 Document type: Article Affiliation country: Germany Country of publication: Austria